Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Kalorama Reports | Drug Delivery Markets Vol IV Transdermal

Drug Delivery Markets Vol IV Transdermal

New biological treatments are being developed at a record place, but their potential could be compromised by significant obstacles to delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product. New systems are being developed, and Kalorama's Drug Delivery Markets Series covers these new systems.

The fourth volume of this series, Kalorama's Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery is a complete overview of a delivery mechansim that offers some advantages: low pain, infection risk, fewer side effects and polonged delivery over time.

Transdermal delivery has the advantage of being able deliver drugs over a long period of time, deliver a substantial amount and do so in a way that causes no pain or discomfort to the patient.

Nicotine patches have lead the growth in this delivery area, but new biological formulations will lead to continued growth.

Kalorama's Drug Delivery Series, Volume 4, Transdermal/Transmucosal Delivery covers the entire market of drugs delivered through the skin or muocus membrane. The transdermal/transmucosal drug delivery market is expected to grow steadily with biotechnology drugs that require novel delivery technologies leading this growth. The volume features

Complete Round-Up of Key Companies

Current Market Size for transdermal and transmucosal segments, as well as the pharmaceutical and technology-only segments

Forecasts to 2011 for Strategic Business Planning

Market coverage includes both the pharmaceutical products that utilize the drug delivery technology. The second section encompasses drug delivery technology and the revenues earned from licensing that technology. Because drug delivery technology is an integral part of sales of pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that include pharmaceutical sales for products utilizing that technology.

This market is expected to increase substantially within the forecast period. Additionally, a growing focus on ease of delivery to assist in patient compliance could help drive demand for both transdermal and transmucosal delivery systems.

Apr 1, 2007

118 Pages

PDF Format
Table of Contents
Price: $2,495.00 / €1,669.16

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions